Literature DB >> 16470411

Estimating radiation-induced cancer risks at very low doses: rationale for using a linear no-threshold approach.

David J Brenner1, Rainer K Sachs.   

Abstract

The possible cancer risks caused by ionizing radiation doses of ~1 mSv or less are too small to be estimated directly from epidemiological data. The linear no-threshold (LNT) approach to estimating such risks involves using epidemiological data at higher (but still low) doses to establish an "anchor point", and then extrapolating the excess cancer risk linearly down from this point to the low dose of interest. The study in this issue by Professor Tubiana and colleagues, summarizing a French Academy of Sciences report, argues that such LNT extrapolations systematically give substantial overestimates of the excess cancer risk at very low doses. We suggest that, to the contrary, even if there are significant deviations from linearity in the relevant dose range, potentially caused by the effects of inter-cellular interactions or immune surveillance, we know almost nothing quantitatively about these effects. Consequently, we do not know the magnitude, nor even the direction of any such deviations from linearity-the risks could indeed be lower than those predicted by a linear extrapolation, but they could well be higher.

Entities:  

Mesh:

Year:  2006        PMID: 16470411     DOI: 10.1007/s00411-006-0029-4

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  13 in total

Review 1.  Fundamental concepts of the angiogenic process.

Authors:  Judah Folkman
Journal:  Curr Mol Med       Date:  2003-11       Impact factor: 2.222

Review 2.  Risk of childhood cancer from fetal irradiation.

Authors:  R Doll; R Wakeford
Journal:  Br J Radiol       Date:  1997-02       Impact factor: 3.039

3.  Escape of small numbers of allogeneic lymphoma cells from immune surveillance.

Authors:  E Bonmassar; E Menconi; A Goldin; G Cudkowicz
Journal:  J Natl Cancer Inst       Date:  1974-08       Impact factor: 13.506

4.  Tumor escape from immune elimination: simplified precursor bound cytotoxicity models.

Authors:  R J De Boer; P Hogeweg
Journal:  J Theor Biol       Date:  1985-04-21       Impact factor: 2.691

Review 5.  Integrative radiation carcinogenesis: interactions between cell and tissue responses to DNA damage.

Authors:  Mary Helen Barcellos-Hoff
Journal:  Semin Cancer Biol       Date:  2004-12-30       Impact factor: 15.707

6.  Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.

Authors:  W C Black; H G Welch
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

7.  Radiation carcinogenesis at low doses.

Authors:  H H Rossi; A M Kellerer
Journal:  Science       Date:  1972-01-14       Impact factor: 47.728

Review 8.  Tumor-stroma interactions.

Authors:  Neil A Bhowmick; Harold L Moses
Journal:  Curr Opin Genet Dev       Date:  2005-02       Impact factor: 5.578

9.  Cancer risks attributable to low doses of ionizing radiation: assessing what we really know.

Authors:  David J Brenner; Richard Doll; Dudley T Goodhead; Eric J Hall; Charles E Land; John B Little; Jay H Lubin; Dale L Preston; R Julian Preston; Jerome S Puskin; Elaine Ron; Rainer K Sachs; Jonathan M Samet; Richard B Setlow; Marco Zaider
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

Review 10.  Childhood cancer after prenatal exposure to diagnostic X-ray examinations in Britain.

Authors:  R H Mole
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

View more
  40 in total

1.  Evidence for formation of DNA repair centers and dose-response nonlinearity in human cells.

Authors:  Teresa Neumaier; Joel Swenson; Christopher Pham; Aris Polyzos; Alvin T Lo; PoAn Yang; Jane Dyball; Aroumougame Asaithamby; David J Chen; Mina J Bissell; Stefan Thalhammer; Sylvain V Costes
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-19       Impact factor: 11.205

2.  A pediatric CT dose and risk estimator.

Authors:  Adam M Alessio; Grace S Phillips
Journal:  Pediatr Radiol       Date:  2010-07-11

3.  JCCA 2006;50 (3):172-181. Oakley P, Harrison DD, Harrison DE, Haas J. A rebuttal to chiropractic radiologists' view of the 50 year old, linear-no-threshold radiation risk model (commentary).

Authors:  André E Bussières; Carlo Ammendolia; Cindy Peterson; John A M Taylor
Journal:  J Can Chiropr Assoc       Date:  2006-12

4.  LNT: a never-ending story.

Authors:  Anna A Friedl; Werner Rühm
Journal:  Radiat Environ Biophys       Date:  2006-03       Impact factor: 1.925

5.  A perspective on the scientific, philosophical, and policy dimensions of hormesis.

Authors:  George R Hoffmann
Journal:  Dose Response       Date:  2009-01-19       Impact factor: 2.658

6.  Overestimation of Chernobyl consequences: biophysical aspects.

Authors:  Sergei V Jargin
Journal:  Radiat Environ Biophys       Date:  2009-04-07       Impact factor: 1.925

7.  Preconditioned alternating projection algorithm for solving the penalized-likelihood SPECT reconstruction problem.

Authors:  Si Li; Jiahan Zhang; Andrzej Krol; C Ross Schmidtlein; David Feiglin; Yuesheng Xu
Journal:  Phys Med       Date:  2017-05-09       Impact factor: 2.685

8.  Effective dose estimation and lifetime cancer mortality risk assessment from exposure to Chernobyl 137Cs on the territory of Belgrade City and the region of Vojvodina, Serbia.

Authors:  Vesna Spasić-Jokić; Ljubica Zupunski; Ljiljana Janković; Vojin Gordanić
Journal:  Environ Sci Pollut Res Int       Date:  2011-04-05       Impact factor: 4.223

9.  Quantifying Cancer Risk from Radiation.

Authors:  Alexander P Keil; David B Richardson
Journal:  Risk Anal       Date:  2017-12-06       Impact factor: 4.000

Review 10.  Current knowledge on tumour induction by computed tomography should be carefully used.

Authors:  Cristian Candela-Juan; Alegría Montoro; Enrique Ruiz-Martínez; Juan Ignacio Villaescusa; Luis Martí-Bonmatí
Journal:  Eur Radiol       Date:  2013-11-27       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.